Follow
Hugo Botha
Hugo Botha
Behavioral Neurologist, Mayo Clinic
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum
DT Jones, J Graff-Radford, VJ Lowe, HJ Wiste, JL Gunter, ML Senjem, ...
Cortex 97, 143-159, 2017
2172017
Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech
H Botha, JR Duffy, JL Whitwell, EA Strand, MM Machulda, CG Schwarz, ...
Cortex 69, 220-236, 2015
1952015
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
CR Jack, HJ Wiste, H Botha, SD Weigand, TM Therneau, DS Knopman, ...
Brain, 2019
1752019
Prosodic and phonetic subtypes of primary progressive apraxia of speech
RL Utianski, JR Duffy, HM Clark, EA Strand, H Botha, CG Schwarz, ...
Brain and Language 184, 54-65, 2018
1532018
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy
F Ali, PR Martin, H Botha, JE Ahlskog, JH Bower, JY Masumoto, ...
Movement Disorders, 2019
1292019
Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes
RA Townley, J Graff-Radford, WG Mantyh, H Botha, AJ Polsinelli, ...
Brain Communications, 2020
1172020
Deep learning-based brain age prediction in normal aging and dementia
J Lee, B Burkett, HK Min, M Senjem, E Lundt, H Botha, J Graff-Radford, ...
1162021
Predicting future rates of tau accumulation on PET
CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau, VJ Lowe, DS Knopman, ...
Brain 143 (10), 3136-3150, 2020
972020
Primary Progressive Aphasias and Apraxia of Speech
H Botha, KA Josephs
CONTINUUM: Lifelong Learning in Neurology 25 (1), 101-127, 2019
902019
Associations of Quantitative Susceptibility Mapping with Alzheimer's Disease Clinical and Imaging Markers
PM Cogswell, HJ Wiste, ML Senjem, JL Gunter, SD Weigand, ...
NeuroImage, 117433, 2020
882020
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis
H Botha, WG Mantyh, ME Murray, DS Knopman, SA Przybelski, HJ Wiste, ...
Brain 141 (4), 1201-1217, 2018
882018
[18F]AV‐1451 tau‐PET and primary progressive aphasia
KA Josephs, PR Martin, H Botha, CG Schwarz, JR Duffy, HM Clark, ...
Annals of neurology 83 (3), 599-611, 2018
862018
Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
JL Whitwell, N Tosakulwong, H Botha, F Ali, HM Clark, JR Duffy, ...
NeuroImage: Clinical, 102152, 2019
772019
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants
N Zalewski, H Botha, JL Whitwell, V Lowe, DW Dickson, KA Josephs
Journal of neurology 261 (4), 710-716, 2014
772014
Attention and visual dysfunction in Parkinson's disease
H Botha, J Carr
Parkinsonism & Related Disorders 18 (6), 742-747, 2012
772012
Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis
H Botha, C Ackerman, S Candy, JA Carr, S Griffith-Richards, KJ Bateman
PloS one 7 (6), e38982, 2012
762012
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
AM Staffaroni, M Quintana, B Wendelberger, HW Heuer, LL Russell, ...
Nature Medicine, 1-13, 2022
752022
Cerebral microbleeds: Prevalence and relationship to amyloid burden
J Graff-Radford, H Botha, AA Rabinstein, JL Gunter, SA Przybelski, ...
Neurology 92 (3), e253-e262, 2019
732019
A computational model of neurodegeneration in Alzheimer’s disease
D Jones, V Lowe, J Graff-Radford, H Botha, L Barnard, D Wiepert, ...
Nature communications 13 (1), 1-13, 2022
682022
Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer’s Disease
I Sintini, J Graff-Radford, DT Jones, H Botha, PR Martin, MM Machulda, ...
Cerebral Cortex, 2020
672020
The system can't perform the operation now. Try again later.
Articles 1–20